Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis

Laboratory Investigation

Volumn 79, Issue 2, 1999, Pages 185-194

  Alonso, Javier ^a   Mampaso, Francisco ^b   Martín, Ana ^b   Palacios, Itziar ^a   Egido, Jesús ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RAT; WOUND HEALING;

ACUTE DISEASE; ALTERNATIVE SPLICING; ANIMALS; DISEASE PROGRESSION; FIBRONECTINS; GLOMERULAR MESANGIUM; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; INTEGRINS; ISOMERISM; MALE; NEPHRITIS; RATS; RATS, WISTAR; RECEPTORS, LYMPHOCYTE HOMING; RNA, MESSENGER; TIME FACTORS;

EID: 0033049812     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alonso J, Gómez-Chiarri M, Ortíz A, Serón D, Condom E, López-Armada MJ, Largo R, Barat A, and Egido J (1996). Glomerular upregulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. Kidney Int 50:908-919.
2. Bagchus WM, Hoedemaeker PJ, Rozing J, and Bakker WW (1986). Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 55:680-687.
3. Bergijk EC, Munaut C, Baelde JJ, Prins F, Foidart JM, Hoedemaker PJ, and Bruijn JA (1992). A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease. Am J Pathol 140:1147-1156.
4. Borsi L, Carnemolla B, and Castellani P (1987). Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol 104: 595-600.
5. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Cosio FG, Sedmak DD, and Nahman NS (1990). Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int 38:886-895.
7. Couchman JR, Beavan LA, and McCarthy KJ (1994). Glomerular matrix: Synthesis, turnover and role in mesangial expansion. Kidney Int 45:328-335.
8. Ding G, Pesek Diamond I, and Diamond JR (1993). Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis. Am J Physiol 264:F577-F584.
9. Elices MJ, Tsai V, Strahl D, Goel AS, Tollefson V, Arrhenius T, Wayner EA, Gaeta FCA, Fikes JD, and Firestein GS (1994). Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 93:405-416.
10. Farhadian F, Barrieux A, Lortet S, Marotte F, Oliviero P, Rappaport L, and Samuel JL (1994). Differential splicing of fibronectin pre-messenger ribonucleic acid during cardiac ontogeny and development of hypertrophy in the rat. Lab Invest 71:552-559.
11. Ffrench-Constant C and Hynes RO (1988). Patterns of fibronectin gene expression and splicing during cell migration in chicken embryos. Development 104:369-382.
12. Ffrench-Constant C and Hynes RO (1989). Alternative splicing of fibronectin is temporally and spatially regulated in the chicken embryo. Development 106:375-388.
13. Ffrench-Constant C, De Water LV, Dvorak HF, and Hynes RO (1989). Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914.
14. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, and Johnson RJ (1992). Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497.
15. García Pardo A, Wayner EA, Carter WG, and Ferreira OC (1990). Human B lymphocytes define an alternative mechanism of adhesion to fibronectin. J Immunol 144:3361-3366.
16. Gómez-Chiarri M, Ortiz A, Lerma JL, Mampaso F, González E, and Egido J (1994). Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 70:449-459.
17. Goyal M and Wiggins R (1991). Fibronectin mRNA and protein accumulation, distribution, and breakdown in rabbit anti-glomerular basement membrane disease. J Am Soc Nephrol 1:1334-1342.
18. Guan JL and Hynes RO (1990). Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell 60:53-61.
19. Hynes RO (1990). Fibronectins. Rich A, editor. New York: Springer-Verlag.
20. Jamagin WR, Rockey DC, Koteliansky VE, Wang SS, and Bissel DM (1994). Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 127:2037-2048.
21. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzl P, Gordon K, and Gown AM (1991). Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. J Clin Invest 87:847-858.
22. Klahr S, Schreiner G, and Ichikawa I (1988). The progression of renal disease. N Engl J Med 318:1657-1666.
23. Kuhn C and McDonald JA (1991). The roles of the myofibroblasts in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 138:1257-1265.
24. Kurki P, Vanderlaan M, Dolbeare F, Gray J, and Tan EM (1986). Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-214.
25. Lobb RR and Hemler ME (1994). The pathophysiologic role of alpha 4 integrins in vivo. J Clin Invest 94:1722-1728.
26. Mamuya WS and Brecher P (1992). Fibronectin expression in the normal and hypertrophic rat heart. J Clin Invest 89:392-401.
27. Pagani F, Zagato L, Vergani C, Casari G, Sidoli A, and Baralle FE (1991). Tissue-specific pattern of fibronectin messenger RNA during development and aging in rat. J Cell Biol 266: 1223-1229.
28. Quirós J, González Cabrero J, Egido J, Herrero-Beaumont G, and Martínez Montero JC (1990). Beneficial effect of fibronectin administration on chronic serum sickness in rats. Arthritis Rheum 33:685-692.
29. Rabb H, Rosen R, and Ramirez G (1995). VLA-4 and its ligands: Relevance to kidney diseases. Springer Semin immunopathol 16:417-425.
30. Roy Chaudhury P, Wu B, McDonald S, Haites NE, Simpson JG, and Power DA (1995). Phenotypic analysis of the glomerular and periglomerular mononuclear cell infiltrates in the Thy 1.1 model of glomerulonephritis. Lab Invest 72:524-531.
31. Ruíz Ortega M, González S, Serón D, Condom E, Bustos C, Largo R, González E, and Egido J (1995). ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1791.
32. Sady SP, Goyal M, Thomas PE, Wharram BL, and Wiggins RC (1995). Fibronectin mRNA in the developing glomerular crescent in rabbit antiglomerular basement membrane disease. J Am Soc Nephrol 5:2087-2090.
33. Sánchez-Madrid F, Landázuri MD, Morago G, Cebrián M, Acevedo A, and Bernabeu C (1986). VLA-3: A novel polypeptide association within VLA molecular complex: Cell distribution and biochemical characterization. Eur J Immunol 16: 1343-1349.
34. Schwarzbauer JE (1991). Alternative splicing of fibronectin: Three variants, three functions. BioEssays 13:527-533.
35. Sterzel RB, Schulze LE, Weber M, and Goodman SL (1992). Interactions between glomerular mesangial cells, cytokines and extracellular matrix. J Am Soc Nephrol 2:S126-S131.
36. Takasaki I, Chobanian AV, Mamuya WS, and Brecher P (1992). Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension 20:20-25.
37. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama M, and Fujishima M (1994). TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536.